Study supports TAVR for lower-risk patients

04/7/2013 | TCTMD.com

Transcatheter aortic valve replacement may be an appropriate treatment for severe aortic stenosis in patients who are at low or intermediate risk for surgery, according to a study published in the European Heart Journal. "Compared with patients at calculated risk, well-selected patients with STS-defined intermediate or low risk appear to have favorable clinical outcomes," the authors of the Swiss study wrote. U.S.-based physicians are hopeful TAVR indications can be broadened if data continue to support doing so, said Dr. William Suh of the University of California, Los Angeles.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR